Clinical Trial Update: Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tigecycline with imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections has completed enrollment and status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Abscess
• Complicated Intra-abdominal Infection

Drugs mentioned

• Primaxin (imipenem/cilastatin)
• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Abdominal Abscess | Phase 3 | Status: COMPLETED